A team led by Professor Guosheng Tang from Guangzhou Medical University, Associate Professor Yutao Liu from Tianjin ...
Synedgen, Inc., a biotechnology company targeting human glycobiology to treat gastrointestinal diseases, today announced the publication of preclinical data that shows MIIST305 mitigating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback